Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Ignoring spatial heterogeneity in drivers of SARS-CoV-2 transmission in the US will impede sustained elimination

Zachary Susswein, Eugenio Valdano, Tobias Brett, Pejman Rohani, View ORCID ProfileVittoria Colizza, Shweta Bansal
doi: https://doi.org/10.1101/2021.08.09.21261807
Zachary Susswein
1Georgetown University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugenio Valdano
2INSERM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Brett
3University of Georgia, Athens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pejman Rohani
3University of Georgia, Athens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vittoria Colizza
2INSERM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vittoria Colizza
Shweta Bansal
1Georgetown University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sb753@georgetown.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

To dissect the transmission dynamics of SARS-CoV-2 in the United States, we integrate parallel streams of high-resolution data on contact, mobility, seasonality, vaccination and seroprevalence within a metapopulation network. We find the COVID-19 pandemic in the US is characterized by a geographically localized mosaic of transmission along an urban-rural gradient, with many outbreaks sustained by between-county transmission. We detect a dynamic tension between the spatial scale of public health interventions and population susceptibility as pre-pandemic contact is resumed. Further, we identify regions rendered particularly at risk from invasion by variants of concern due to spatial connectivity. These findings emphasize the public health importance of accounting for the hierarchy of spatial scales in transmission and the heterogeneous impacts of mobility on the landscape of contagion risk.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Institute of General Medical Sciences of the NIH under Award Number R01GM123007.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Review Board, Georgetown University

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data used comes from accessible data repositories. SARS-CoV-2 data is available from the Centers for Disease Control and Prevention (https://covid.cdc.gov/covid-data-tracker/#county-view, https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/geographic-seroprevalence-surveys.html) and the New York Times (https://github.com/nytimes/covid-19-data). Behavior data is available from Safegraph (https://www.safegraph.com/academics) and the Delphi CTIS (https://delphi.cmu.edu/covidcast/surveys/). All data for the study will be available at https://github.com/bansallab/spatialR

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 10, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Ignoring spatial heterogeneity in drivers of SARS-CoV-2 transmission in the US will impede sustained elimination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Ignoring spatial heterogeneity in drivers of SARS-CoV-2 transmission in the US will impede sustained elimination
Zachary Susswein, Eugenio Valdano, Tobias Brett, Pejman Rohani, Vittoria Colizza, Shweta Bansal
medRxiv 2021.08.09.21261807; doi: https://doi.org/10.1101/2021.08.09.21261807
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Ignoring spatial heterogeneity in drivers of SARS-CoV-2 transmission in the US will impede sustained elimination
Zachary Susswein, Eugenio Valdano, Tobias Brett, Pejman Rohani, Vittoria Colizza, Shweta Bansal
medRxiv 2021.08.09.21261807; doi: https://doi.org/10.1101/2021.08.09.21261807

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (501)
  • Anesthesia (110)
  • Cardiovascular Medicine (1233)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
  • Epidemiology (10012)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2448)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1636)
  • Health Policy (751)
  • Health Systems and Quality Improvement (635)
  • Hematology (248)
  • HIV/AIDS (532)
  • Infectious Diseases (except HIV/AIDS) (11860)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2277)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (453)
  • Occupational and Environmental Health (534)
  • Oncology (1245)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (155)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4828)
  • Radiology and Imaging (834)
  • Rehabilitation Medicine and Physical Therapy (490)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (226)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)